Vical Incorporated Share Price Nasdaq

Stocks

27/01/25	Fresh Tracks Therapeutics Announces Special Distribution	CI
15/03/24	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
21/12/23	Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index	CI
18/12/23	Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from NASDAQ Composite Index	CI
13/11/23	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
20/09/23	Wall Street Set to Open Wednesday Trading Higher as Investors Await Fed Decision on Interest Rates	MT
20/09/23	US Futures Rise Modestly Pre-Bell as Investors Await Fed Rate Decision	MT
20/09/23	Top Premarket Gainers	MT
19/09/23	Fresh Tracks Therapeutics' Board Approves Liquidation Plan; Shares Rise After Hours	MT
19/09/23	Fresh Tracks Therapeutics, Inc. Announces Chief Executive Officer Changes	CI
19/09/23	Fresh Tracks Therapeutics, Inc. Announces Executive Changes	CI
11/08/23	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
25/07/23	Fresh Tracks Therapeutics, Inc. Announces Resignation of Robert B. Brown from the Board of Directors, Effective Immediately	CI

14/11/22	Oppenheimer Adjusts Fresh Tracks Therapeutics Price Target to $4 From $9, Maintains Outperform Rating	MT
27/09/22	Oppenheimer Adjusts Price Target on Fresh Tracks Therapeutics to $9 From $1, Maintains Outperform Rating	MT
16/08/22	HC Wainwright Adjusts Brickell Biotech's Price Target to $4.50 From $2, Keeps Buy Rating	MT
13/05/22	Lake Street Downgrades Brickell Biotech to Hold From Buy, Lowers Price Target to $0.25 From $2	MT
13/05/22	Oppenheimer Adjusts Brickell Biotech's Price Target to $1 From $4, Maintains Outperform Rating	MT

25/02/25	Fresh Tracks Therapeutics Announces Dissolution, Initial Cash Distribution and Termination of Trading on the OTC Pink Market	PR
29/01/25	Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution	AQ
27/01/25	/C O R R E C T I O N -- Fresh Tracks Therapeutics, Inc./	PR
06/12/24	Fresh Tracks Therapeutics Announces Hearing Date and Notice of Proposed Consent Judgement Regarding Dissolution of Company	PR
17/06/24	Fresh Tracks Therapeutics Announces Delaware Petition Filed Seeking Appointment of Custodian for Eventual Dissolution of Company	AQ

08/03/23	MÄRKTE USA/Uneinheitlich - Zinspfad ungewiss
08/03/23	MÄRKTE USA/Uneinheitlich - Zinssorgen bleiben präsent
08/03/23	MÄRKTE USA/Wall Street mit leichter Erholung
08/03/23	MÄRKTE USA/Wall Street stabilisiert nach Vortagesverlusten
08/03/23	MARKT USA/Wall Street stabilisiert nach Vortagesverlusten

1 day

+2.11%

Manager	Title	Age	Since
Albert Marchio CEO	Chief Executive Officer	74	01/10/2023
Nancy Seretta CTO	Chief Tech/Sci/R&D Officer	-	31/12/2015
Aaron Fox-Collis DFI	Director of Finance/CFO	-	31/05/2022

Director	Title	Age	Since
Albert Marchio CHM	Chairman	74	01/10/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VICAL INCORPORATED	+2.11%	-3.76%	-	-	5.59M
WUXI APPTEC CO., LTD.	-7.17%	-2.63%	+49.59%	+74.24%	55.98B
ARGENX SE	+0.24%	-5.62%	+54.73%	+125.15%	53.69B
INSMED INCORPORATED	+0.59%	-6.17%	+4.14%	+424.06%	23.29B
BIONTECH SE	+0.31%	+0.33%	-17.34%	-14.38%	23.15B
WUXI BIOLOGICS (CAYMAN) INC.	-5.95%	-0.22%	+35.96%	-9.58%	20.58B
GENMAB A/S	-1.14%	+0.03%	+31.57%	-30.42%	17.76B
PHARMAESSENTIA CORPORATION	-5.16%	-7.00%	+177.56%	+326.39%	16.09B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-6.91%	+2.40%	+36.86%	+636.97%	15.93B
EXELIXIS, INC.	+0.49%	-1.02%	+24.64%	+191.43%	14B
Average	-2.20%	-1.26%	+44.19%	+191.54%	26.72B
Weighted average by Cap.	-2.85%	-2.20%	+43.66%	+157.02%